REPLIGEN CORP Current Assets
REPLIGEN CORP (RGEN) had Current Assets of $1.20 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-07-29
- 2026-06-30: Assets, Current $1.20B.
- 2026-03-31: Assets, Current $1.16B.
- 2025-12-31: Assets, Current $1.14B.
- 2025-09-30: Assets, Current $1.10B.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.20B 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $1.16B 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $1.14B 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $1.10B 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.06B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.03B 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $1.07B 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.13B 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $1.16B 10-Q/A · filed 2024-11-18 | $1.16B 10-Q · filed 2024-07-30 |
| 2024-03-31 | $1.13B 10-Q/A · filed 2024-11-18 | $1.13B 10-Q · filed 2024-05-01 |
| 2023-12-31 | $1.11B 10-K · filed 2025-03-14 | $1.11B 10-K · filed 2024-02-22 |
| 2023-09-30 | $980.47M 10-Q/A · filed 2024-11-18 | $978.46M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $999.93M 10-Q/A · filed 2024-11-18 | $998.58M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $1.02B 10-Q/A · filed 2024-11-18 | $1.02B 10-Q · filed 2023-05-02 |
| 2022-12-31 | $998.12M 10-Q/A · filed 2024-11-18 | |
| 2022-09-30 | $953.23M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $976.00M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $944.79M 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $931.68M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $910.85M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $983.83M 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $926.34M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $902.38M 10-K · filed 2022-02-17 | |
| 2020-09-30 | $696.73M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $687.16M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $651.38M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $641.83M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $621.54M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $316.49M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $284.08M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $275.74M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $267.25M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $252.91M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $248.32M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $242.78M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $231.19M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $195.94M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $185.80M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $184.15M 10-K · filed 2018-02-22 | |
| 2016-09-30 | $219.83M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $217.94M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $105.25M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $103.25M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $96.28M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $93.27M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $83.51M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $80.95M 10-K · filed 2016-02-25 | $80.95M 10-K · filed 2015-03-17 |
| 2014-09-30 | $75.69M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $73.86M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $88.70M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $86.35M 10-K · filed 2015-03-17 | |
| 2013-09-30 | $87.44M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $80.91M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $70.70M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $66.21M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $53.79M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $52.36M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $50.74M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $46.89M 10-K · filed 2013-03-15 | |
| 2011-09-30 | $60.02M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $52.22M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $55.84M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |